BHC(SH:600721) Zheng Quan Zhi Xing·2025-07-02 16:15Core Viewpoint - The announcement details the stock option incentive plan of Xinjiang Baihua Village Pharmaceutical Group Co., Ltd., highlighting the execution of stock options and the related financial implications for the company [1][9]. Summary by Sections Stock Option Exercise Details - The number of stock options exercised from April 1, 2025, to June 30, 2025, is 149,540 shares, representing 5.90% of the total exercisable stock options. As of June 30, 2025, a total of 2,205,445 shares have been exercised, accounting for 87.06% of the total exercisable stock options [1][9]. - The stock from this exercise will be listed for trading on the second trading day after the exercise date [1]. Decision-Making Process and Disclosure - The decision-making process for the stock option exercise involved several proposals, including the draft of the stock option incentive plan and the management measures for its implementation. Independent directors provided their consent for these matters [2][3]. Adjustments to Incentive Plan - The company has adjusted the list of incentive objects and the number of granted rights, with a total of 1,207,650 stock options being canceled due to non-fulfillment of exercise conditions, reducing the number of incentive objects from 162 to 149 [4][5]. - A total of 2,718,205 stock options were canceled for those who did not meet the exercise conditions, further adjusting the number of incentive objects [6]. Financial Impact and Fundraising - The company raised 744,709.20 yuan from the exercise of 149,540 shares, with a cumulative fundraising of 45,614,409.60 yuan from the total exercised options, which is intended to supplement the company's working capital [9]. - The total number of shares increased from 384,144,335 to 384,293,875, but this change did not significantly impact the company's financial status or operating results [9].